Lucatumumab

Lucatumumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name Lucatumumab
Generic Lucatumumab
Lucatumumab Other Names Lucatumumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Lucatumumab
Lucatumumab

Uses

Investigated for use/treatment in leukemia (lymphoid), multiple myeloma, and lymphoma (unspecified).

How Lucatumumab works

HCD122 is a fully human, antagonist antibody that targets the CD40 antigen. HCD122 binds to tumor cells that express CD40 and antagonizes (prevents) CD40 ligand-mediated growth and survival of malignant B cells. Based on preclinical data, HCD122 also induces antibody-dependent cellular cytotoxicity (ADCC), killing CD40 expressing tumor cells by immune effector cells. This dual mechanism of action makes HCD122 a drug candidate with potential for the treatment of B-cell malignancies.

Innovators Monograph

You find simplified version here Lucatumumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share